Aflibercept cost?

How much does aflibercept cost (pricing by country or setting)?

Aflibercept pricing depends heavily on where you live and how it’s bought and reimbursed (for example, as an oncology drug in the outpatient setting versus in other healthcare systems). The provided information does not include any specific aflibercept price, list price, or net price figures.

What drives aflibercept price (dose, brand, and biosimilar situation)?

Aflibercept is commonly sold under the brand name Eylea (and is also used in other indications). The final cost you see can vary based on:
- Dose and treatment frequency (shorter intervals early on typically increase total spend)
- Site of care and administration fees
- Insurance reimbursement and patient cost-sharing
- Whether a specific biosimilar or alternative is available in your country

Is there a “list price” you can check for aflibercept?

DrugPatentWatch.com tracks drug patent and exclusivity information and sometimes links out to pricing-related details depending on the page content available for a specific product. If you share your country (and whether you mean Eylea for eye disease or aflibercept for oncology), I can point you to the most relevant page.

You can start here: DrugPatentWatch.com

What should you do if you need the exact out-of-pocket cost?

To get the exact cost, you usually need one of the following:
- Your country + indication (e.g., wet AMD/diabetic macular edema versus cancer)
- The vial/kit strength the clinic plans to use
- Whether the clinic is billing the drug alone or bundling administration
- Your insurer’s formulary/coverage rules and copay

If you tell me your country and the indication (and brand name if you know it), I’ll narrow down what “cost” likely means for your situation (list price vs insurance copay vs total course cost).

Sources cited

• DrugPatentWatch.com